<DOC>
	<DOCNO>NCT03027999</DOCNO>
	<brief_summary>Rheumatoid arthritis ( RA ) progressive disease affect mainly small medium joint , absence appropriate background therapy , lead progressive joint destruction , functional , psychological , social occupational repercussion . Several biomedicine treat pathology , include rituximab ( RTX ) . It recommend evaluate therapeutic response RTX re-administer 24th week goal remission achieve . However , optimal modality reprocessing remain determined . To end , different approach explore , lymphocyte type ultrasound monitoring . The pace examination , however , remain wide cost negligible . This propose explore track tight follow-up nurse DAS28 . The hypothesis tight nursing follow-up detect symptomatic recovery earlier current medical follow-up . The hypothesis tight nursing follow-up detect symptomatic recovery earlier current medical follow-up</brief_summary>
	<brief_title>Efficiency Tight Monitoring Nurse Practitioner Rheumatoid Arthritis ( RA ) Patients Remission</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Male female ( age 18 old ) Rheumatoid arthritis fulfil ACR/EULAR 2010 criterion Patient rheumatologist prescribe treatment rituximab receive treatment rituximab last 6 month Patients active rheumatoid arthritis prior treatment rituximab ( DAS 28 CRP &gt; 2.7 ) Patient DAS 28 CRP less 2.7 6 month last administration rituximab Patient respond last treatment rituximab ( DAS28 CRP &gt; 2.7 6 month ) Patient age 18 Patient chronic pain due another pathology rheumatoid arthritis , may interfere assessment Patient contraindication treatment rituximab Woman childbearing age take effective contraception Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rituximab</keyword>
	<keyword>tight monitoring</keyword>
</DOC>